Update: COVID-19 R&D Funding May 19th 2020

Specific COVID-19 related funding opportunities for EU-wide and/or Dutch applicants. Update: 5/19/2020

Close to 30 funding opportunities are open for applicants!

Most recent changes/ new calls that opened this week:

  • EUREKA opened funding for SMEs in specific countries to develop “Solutions for the next human high-impact pandemic”
  • H2020 released 5 new calls for R&D consortia focussing on solutions for COVID-19 and future outbreaks
  • DIGI-B-CUBE  opened a call to support projects focusing on integrating digital innovations and disruptive technologies across the Medical Diagnostics and related value chains
  • NIH funds projects: ‘Rapid Investigation of SARS-CoV-2 and COVID-19’
  • DHSC/UKRI has a new COVID-19 Rapid Response Rolling Call

The full overview of current funding opportunities and relevant (partnering)links is provided here.

Update: COVID-19 R&D Funding May 7th 2020

Specific COVID-19 related funding opportunities for EU-wide and/or Dutch applicants. Update: 5/07/2020

Over 20 Dutch and EU-wide calls are open to apply for funding to cover your COVID-19 related R&D projects!

In May, many new funding opportunities and partnering events are launched (and closing!) – be aware that fast action is needed!

  • ZonMW and NWO (Dutch research funding) opened 3 calls with deadlines on May 14th and May 25th
  • New funding opportunities are now open from CEPI.
  • The new COVID-19 funding round by HORIZON is still expected to be launched by mid-May.

The full overview of current funding opportunities and relevant (partnering)links are provided here.

Update: COVID-19 R&D Funding May 1st 2020

Specific COVID-19 related funding opportunities for EU-wide and/or Dutch applicants. Update: 5/01/2020

Over 15 Dutch and EU-wide funding bodies are now  lined-up to fund research and development projects to solve all challenges related to the COVID-19 outbreak.

In May many new funding opportunities and partnering events are launched (and closing!) – be aware that fast action is needed!

  • ZonMW and NWO (Dutch research funding) announced Today the first deadlines for funding: May 14th
  • You can still sign up for the Health~Holland COVID-19 virtual partnering event on May 4th.
  • New funding opportunities are now open from PRACE, EGI and AMable.
  • The new COVID-19 funding round by HORIZONis expected to be launched mid-May.

The full overview of current funding opportunities and relevant (partnering)links are provided here.

Update: COVID-19 R&D Funding April 23rd 2020

Specific COVID-19 related funding opportunities for EU-wide and/or Dutch applicants. Update: 4/23/2020

Since this Monday’s update, new events and funding have become available!

  • The EU-wide COVID-19 Data Platform is open.
  • Sign up for the Health~Holland COVID-19 virtual partnering event on May 4th.
  • New funding opportunities are open from SNN, EIT Digital and IsDB.
  • The program text with the scope and timing of the ‘Second Wave’ of Dutch government funding for COVID-19 has become available.

The full overview, details and relevant links are provided here.

Contribute now to the Life Science business projects of the new generation of innovators!

Support the next generation of Life Science entrepreneurs to graduate in 2020. Update: 4/21/2020

Dear life science entrepreneurs,

Currently, the upcoming generation of life science experts is facing a unique challenge to graduate in time. Students are dependent of conducting interviews with early phase entrepreneurs that operate in the life science sector. In order to support them, we would like to appeal to everyone in the industry to contribute. Thirty minutes of your time will have a significant impact on their ability to graduate and add valuable empirical insights to our collective knowledge base. If you haven’t been approached already, we would like to ask you to sign up for (one of the) following projects.

  • Project 1: Identifying key quality indicators during the initial screening phase according to both European institutional VCs and early stage life science firms.
  • Project 2: Towards a unified market intelligence model for innovation-based SMEs and start-ups in the Netherlands.
  • Project 3: Investment strategies for European disease-focused foundations to achieve their venture philanthropy goals.

Who is eligible?

  • Life science startups en SMEs
  • Disease-focused foundations (European)
  • Health funds (European)

What do you sign up for?

  • An interview of approximately 30 minutes, or a potential questionnaire

Where can you sign up?

Email to maarten.korving@ffund.nl (project 1), or victor.bakker@ffund.nl (project 2), or Tessa.vandererve@ffund.nl (project 3).

More information

Click here for more details about the current life Science business research projects that are looking for your support.

Update: COVID-19 R&D Funding April 20th 2020

Specific COVID-19 related funding opportunities for EU-wide and/or Dutch applicants. Update: 4/20/2020

EUREKA, CEPI and EDCTP have released new funding opportunities. Further, information on the scope and timing of release of the ‘Second Wave’ of Dutch government funding for COVID-19 has become available.

Open calls:

  • CEPI – Centralized laboratory for measurement of immune responses elicited
  • EUREKA – Multilateral call for solutions for COVID-19 Echo Period – Life without a vaccine
  • DIH-HERO – Digital Innovation Hubs In Healthcare Robotics Technology Transfer Experiments
  • EDCTP – 4 calls are open
  • JEDI – Billion Molecules Against COVID19 Challenge
  • EIT Health – Business plan 2021, Topics related to prevention, management of pandemics
  • SIDN FONDS – Internet against Corona

The full overview and details relevant to you are provided here.

Update: COVID-19 R&D Funding April 16th 2020

Specific COVID-19 related funding opportunities for EU-wide and/or Dutch applicants. Update: 4/16/2020

Closed calls:

  • Corona Fast Track Data call for Dutch applicants
  • Epidemic Preparedness: COVID-19 funding call from Wellcome Trust.

Open calls:

  • The Health Holland PPP call for COVID-19 has been extended.
  • Fighting COVID-19 call from DIH-HERO was released.

Further, we are waiting on the ‘Second Wave’ of Dutch government funding for COVID-19 to be released shortly.

And we link to 10 collaborative initiatives that have been launched and to which you might want to link your work.

The full overview and details relevant to you are provided here.

COVID-19 R&D Funding Opportunities

Specific COVID-19 related funding opportunities for EU-wide and/or Dutch applicants. Update: 4/8/2020

Main European non-dilutive funding options:

  • EDCTP Grant – For COVID-19 research in sub-Saharan Africa (Deadline 17th April)

Main Dutch non-dilutive funding (as of today):

  • Health Holland Special Announcement COVI-19 – PPP for solutions related to COVID-19 (Deadline 10th April).

Extension for new applications likely.

  • Corona: fast-track data: For collection of data from current patients (continuous application up to 1stSeptember)
  • Information regarding new upcoming funding opportunities for COVID-19 research through NWO, ZonMw and other Dutch organizations are being published, including opportunities to collaborate with existing consortiums tackling COVID-19.

The full overview and details relevant to you are provided here.

Life Sciences experts

Our consultants have subject-matter expertise (Postdoc, PhD, MD, MSc) in Life Sciences fields.

Tailored advice

Our consultancy services span the entire Life Sciences value chain, and are always tailored to your specific needs.

Experienced business managers

We have experienced the challenges of managing Life Sciences companies through all different stages, from start-up to controlled growth and successful exit.

Active support

We aim to be a true partner for advice, taking an active, hands-on approach to service provision.

Innovation specialists

For our consultancy, we draw on our continuous academic work on Life Sciences innovation, providing you with evidence-based advice.

International network

We operate at the heart of a vast network of Life Sciences organizations, allowing us to connect and create synergistic partnerships.

Being candid about the risks and opportunities

Being candid about the risks and opportunities that lie ahead of you, we operate from our first-hand experience and expertise to help you and your innovations to become successful. Together we will maximize your chances of success by tailoring our support to your specific needs. This enables you to effectively manage your innovation throughout the complete value chain from the early start, through controlled growth, until a successful exit.